No Data
MEDICSKIN: Interim Report 2024
MEDICSKIN: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
We Think Shareholders May Want To Consider A Review Of Medicskin Holdings Limited's (HKG:8307) CEO Compensation Package
MEDICSKIN: ANNUAL REPORT 2023/24
Express News | Corrected-Medicskin Holdings FY Net Income HKD -3.048 Million (Corrects Amount)
Medicskin (08307) released its annual performance, with shareholders' attributable losses of HKD 3.048 million, a year-on-year narrowing of 13.8%.
Zhītōng Cáijīng APP news, Medicskin (08307) announced its annual results for the year ending March 31, 2024, with revenue of HKD 49.135 million, up 7.9% year-on-year; the company's net loss attributable to owners was HKD 3.048 million, narrowing by 13.8% year-on-year; basic loss per share was HKD 0.77. The reduction in losses during the period was mainly due to a follow-up adjustment made for employee costs of HKD 700,000 recognized in the comprehensive income statement for the year ended March 31, 2023, while the employee cost associated with the long-term service obligation recognized for the year ended March 31, 2024 was HKD 100,000. This adjustment is...
No Data